Alizapride hydrochloride
-
Alizapride hydrochloride
structure -
-
CAS No:
59338-87-3
-
Formula:
C16H22ClN5O2
-
Chemical Name:
Alizapride hydrochloride
-
Synonyms:
6-methoxy-n-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2h-benzotriazole-5-carboxamide hydrochloride;alizapride hydrochloride;Alizapride HCl;6-Methoxy-N-{[(2S)-1-(prop-2-en-1-yl)pyrrolidin-2-yl]Methyl}-2H-1,2,3-benzotriazole-5-carboxaMide;N-((1-Allylpyrrolidin-2-yl)methyl)-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamide hydrochlori;N-((1-Allylpyrrolidin-2-yl)Methyl)-6-Methoxy-1H-benzo[d][1,2,3]triazole-5-carboxaMide hydrochloride;1H-Benzotriazole-5-carboxamide,6-methoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]-, hydrochloride (1:1);-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamide hydrochloride
- Categories:
-
CAS No:
Description
Alizapride hydrochloride is a dopamine receptor antagonist with prokinetic and antiemetic effects which can also be used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
Drug Information
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
alizapride
Alizapride hydrochloride Use and Manufacturing
Alizapride is a dopamine antagonist with prokinetic and antiemetic effects. Alizapride is used in t he treatment of post-operative nausea and vomitting.
Computed Properties
Molecular Weight:351.8
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:6
Exact Mass:351.1462027
Monoisotopic Mass:351.1462027
Topological Polar Surface Area:83.1
Heavy Atom Count:24
Complexity:433
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Alizapride hydrochloride
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Latest News on Alizapride hydrochloride
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9